EPH193 The Role of Adjuvant Atezolizumab in Reducing Recurrence-Related Treatment Costs in Resected Early-Stage PD-L1 High Non-Small Cell Lung Cancer across Europe
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1234
https://www.valueinhealthjournal.com/article/S1098-3015(23)04364-4/fulltext
Title :
EPH193 The Role of Adjuvant Atezolizumab in Reducing Recurrence-Related Treatment Costs in Resected Early-Stage PD-L1 High Non-Small Cell Lung Cancer across Europe
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04364-4&doi=10.1016/j.jval.2023.09.1234
First page :
Section Title :
Open access? :
No
Section Order :
10712